Skip to content
All Sections
Subscribe Now
70°F
Wednesday, August 14th 2024
e-Edition
Home Page
Close Menu
News
News
Crime and Public Safety
Investigative Reporting
Politics
Health
Environment
Business
Best Reviews
Housing
Jobs
Local News
Local News
Long Beach
Los Angeles
Los Angeles County
Sports
Sports
High School Sports
Chargers
Rams
Lakers
Clippers
Dodgers
Angels
College Sports
UCLA Sports
USC Sports
Long Beach State sports
Kings
Ducks
Olympics
Boxing/MMA
Soccer
Horse Racing
Things To Do
Things To Do
Restaurants Food and Drink
Movies
Music + Concerts
Theater
TV and Streaming
Home + Garden
Travel
Amusement Parks
Comics
Puzzles
Events
Obituaries
Obituaries
News Obituaries
Place an Obituary
Opinion
Opinion
Editorials
Opinion Columns
Commentary
Letters to the Editor
Editorial Board
Endorsements
The Grunion
The Grunion
News
Education
Sports
Things to Do
Opinion
E-Edition
Advertising
Contact Us
SCNG Premium
The T.E.A.
Subscribe
Press-Telegram Store
Log In
Logout
Close Menu
Get the latest news delivered daily!
Sign Up
Subscribe
Log In
Account Settings
Contact Us
Log Out
Spoof a user
Get the latest news delivered daily!
Sign Up
Subscribe
Log In
Search
Press Telegram
70°F
Wednesday, August 14th 2024
e-Edition
News
Local News
Sports
Things to Do
Obituaries
Opinion
The T.E.A.
Trending:
Long Beach's Olympic moment
Joe Jost’s turns 100
New electricity charge
How to see the pandas ð¼
LA Olympics a bad idea?
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gemini Therapeutics Inc
(NQ:
GMTX
)
N/A
UNCHANGED
Last Price
Updated: 3:59 PM EST, Dec 29, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
1.090 (20)
Ask (Size)
1.330 (1)
Prev. Close
1.350
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Gemini Therapeutics, Inc. (GMTX) Investigation
February 21, 2023
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Why Minerva Surgical Shares Are Trading Higher By 166%; Here Are 26 Stocks Moving Premarket
December 28, 2022
Gainers Minerva Surgical, Inc. (NASDAQ: UTRS) shares rose 166% to $0.4327 in pre-market trading after the company reported a $30 million private placement of common stock led by Accelmed Partners.
Via
Benzinga
Performance
More News
Read More
7 Short-Squeeze Stocks for Bold Contrarians to Consider
November 21, 2022
Via
InvestorPlace
Gemini Therapeutics Announces Reverse Merger Pact With Hematology-Focused Company
August 10, 2022
Via
Benzinga
GEMINI THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Gemini Therapeutics, Inc. - GMTX
August 12, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
GMTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Merger of Gemini Therapeutics, Inc. Is Fair to Shareholders
August 10, 2022
From
Halper Sadeh LLP
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
August 10, 2022
Via
Benzinga
Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial
August 10, 2022
Via
Benzinga
Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday
August 11, 2022
Via
Benzinga
Gemini Therapeutics and Disc Medicine Announce Merger Agreement
August 10, 2022
From
Gemini Therapeutics, Inc.
Via
Business Wire
The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Booster Data In Kids, Regeneron's COVID-19 Therapy Decision Pushed, Protagonist's Rusfertide Breakthrough Tag Update And More
April 14, 2022
Via
Benzinga
10 Biggest Price Target Changes For Friday
March 11, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 11, 2022
March 11, 2022
Via
Benzinga
What 5 Analyst Ratings Have To Say About Gemini Therapeutics
March 03, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2022
March 03, 2022
Via
Benzinga
10 Biggest Price Target Changes For Thursday
March 03, 2022
Via
Benzinga
Read Why Did Jefferies Downgrade Gemini Therapeutics To Hold
March 01, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 01, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2022
March 01, 2022
Via
Benzinga
10 Biggest Price Target Changes For Tuesday
March 01, 2022
Via
Benzinga
Gemini Therapeutics Provides Corporate Update
February 28, 2022
From
Gemini Therapeutics, Inc.
Via
Business Wire
Gemini Therapeutics Provides GEM103 Program Update
January 10, 2022
From
Gemini Therapeutics, Inc.
Via
Business Wire
46 Biggest Movers From Yesterday
December 16, 2021
Via
Benzinga
Mid-Afternoon Market Update: Dow Surges Over 100 Points After Federal Reserve's Policy Update
December 15, 2021
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 15, 2021
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Close